BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budzyński J, Koziński M, Kłopocka M, Kubica JM, Kubica J. Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol. 2014;103:855-886. [PMID: 24817551 DOI: 10.1007/s00392-014-0720-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Biscetti F, Nardella E, Cecchini AL, Landolfi R, Flex A. The Role of the Microbiota in the Diabetic Peripheral Artery Disease. Mediators Inflamm 2019;2019:4128682. [PMID: 31205450 DOI: 10.1155/2019/4128682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Watanabe J, Hamasaki M, Kotani K. The Effect of Helicobacter pylori Eradication on Lipid Levels: A Meta-Analysis. J Clin Med 2021;10:904. [PMID: 33668848 DOI: 10.3390/jcm10050904] [Reference Citation Analysis]
3 Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112:212-239. [PMID: 28071659 DOI: 10.1038/ajg.2016.563] [Cited by in Crossref: 515] [Cited by in F6Publishing: 415] [Article Influence: 103.0] [Reference Citation Analysis]
4 Guevara B, Cogdill AG. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies. Dig Dis Sci 2020;65:1917-31. [PMID: 32170476 DOI: 10.1007/s10620-020-06193-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
5 Ziganshina EE, Sharifullina DM, Lozhkin AP, Khayrullin RN, Ignatyev IM, Ziganshin AM. Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis. PLoS One 2016;11:e0164836. [PMID: 27736997 DOI: 10.1371/journal.pone.0164836] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
6 Krintus M, Kozinski M, Fabiszak T, Kuligowska-prusinska M, Laskowska E, Lennartz L, Nowak-los L, Kubica J, Sypniewska G. Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I. Clinica Chimica Acta 2016;462:193-200. [DOI: 10.1016/j.cca.2016.09.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Budzyński J, Wiśniewska J, Ciecierski M, Kędzia A. Association between Bacterial Infection and Peripheral Vascular Disease: A Review. Int J Angiol. 2016;25:3-13. [PMID: 26900306 DOI: 10.1055/s-0035-1547385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
8 Feng L, Jian R, Wang Y, Yao Y, Gao M, Du H. A close relationship between Helicobacter pylori infection and the serum level of CD47 in adults. Scand J Gastroenterol 2020;55:640-5. [PMID: 32493095 DOI: 10.1080/00365521.2020.1772863] [Reference Citation Analysis]
9 Hobl EL, Reiter B, Schoergenhofer C, Schwameis M, Derhaschnig U, Lang IM, Stimpfl T, Jilma B. Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers. Clin Res Cardiol 2016;105:349-55. [PMID: 26493304 DOI: 10.1007/s00392-015-0927-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
10 Lai CY, Yang TY, Lin CL, Kao CH. Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2015;34:69-74. [PMID: 25063740 DOI: 10.1007/s10096-014-2207-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hofmann R, Bäck M. Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome. Front Cardiovasc Med 2021;8:764478. [PMID: 34869678 DOI: 10.3389/fcvm.2021.764478] [Reference Citation Analysis]
12 Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2015;20:125-132. [PMID: 25382033 DOI: 10.1111/hel.12182] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
13 赵丽梅, 冯志杰. 幽门螺杆菌感染与心血管疾病. 世界华人消化杂志 2017; 25(14): 1255-1264 [DOI: 10.11569/wcjd.v25.i14.1255] [Reference Citation Analysis]